Cargando…

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control

Detalles Bibliográficos
Autores principales:	Lundqvist, Andreas, Mao, Yumeng, Zhang, Xiaonan, Wennerberg, Erik, Van Hoef, Vincent, Larsson, Ola, Linder, Stig, Kiessling, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649304/ http://dx.doi.org/10.1186/2051-1426-3-S2-P232

Ejemplares similares

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
por: Nandagopal, Neethi, et al.
Publicado: (2014)

mTOR-sensitive translation: Cleared fog reveals more trees
por: Masvidal, Laia, et al.
Publicado: (2017)

The metabolic checkpoint kinase mTOR is essential for interleukin-15 signaling during NK cell development and activation
por: Marçais, Antoine, et al.
Publicado: (2014)

mTOR coordinates protein synthesis, mitochondrial activity and proliferation
por: Morita, Masahiro, et al.
Publicado: (2015)

IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
por: Ali, Alaa Kassim, et al.
Publicado: (2015)

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia
por: Bou-Tayeh, Berna, et al.
Publicado: (2021)

Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes
por: Livingstone, Mark, et al.
Publicado: (2015)

Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells
por: Viel, Sébastien, et al.
Publicado: (2017)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
por: Spormann, Luise, et al.
Publicado: (2020)

Mutant HRAS as novel target for MEK and mTOR inhibitors
por: Kiessling, Michael K., et al.
Publicado: (2015)

Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma
por: Kiessling, Michael K., et al.
Publicado: (2016)

Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells
Publicado: (1996)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma
por: Kiessling, Michael K., et al.
Publicado: (2017)

Interleukin-15 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model
por: Wang, Wei, et al.
Publicado: (2018)

Overview of Research into mTOR Inhibitors
por: Mao, Beibei, et al.
Publicado: (2022)

Role of mTOR in Glucose and Lipid Metabolism
por: Mao, Zhuo, et al.
Publicado: (2018)

Astragalus membranaceus Injection Suppresses Production of Interleukin-6 by Activating Autophagy through the AMPK-mTOR Pathway in Lipopolysaccharide-Stimulated Macrophages
por: Zhang, Xiaoyan, et al.
Publicado: (2020)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
por: Kogure, Toshiaki, et al.
Publicado: (2002)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015)

HIF is not essential for suppression of experimental tumor growth by mTOR inhibition
por: Knaup, Karl X., et al.
Publicado: (2017)

Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
por: Li, Yuhong, et al.
Publicado: (2020)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014)

Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
por: Lin, Shao Jian, et al.
Publicado: (2015)

An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva
por: Hino, Kyosuke, et al.
Publicado: (2018)

Wubeizi Ointment Suppresses Keloid Formation through Modulation of the mTOR Pathway
por: Tang, Zhiming, et al.
Publicado: (2020)

IFN-γ mediates Paneth cell death via suppression of mTOR
por: Araujo, Alessandra, et al.
Publicado: (2021)

Fasting promotes acute hypoxic adaptation by suppressing mTOR-mediated pathways
por: Zhao, Ruzhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l7r96582808tee272uq7osg41h